Podcasts about cvs health

Josh Weiner, senior vice president of consumer engagement and analytics at CVS Health, is passionate about making health care more personalized, connected, preventative, and accessible. On today's episode, Josh joins Sam and Shervin to explain how the integrated health care company is structured and how it is using AI to achieve those goals. Read the episode transcript here. Me, Myself, and AI is a collaborative podcast from MIT Sloan Management Review and Boston Consulting Group and is hosted by Sam Ransbotham and Shervin Khodabandeh. Our engineer is David Lishansky, and the executive producer is Allison Ryder. Guest bio At CVS Health, where Josh Weiner is the senior vice president of consumer engagement and analytics, his priority is personalizing consumer experiences and developing the health care company's app. Previously, he was a health care leader at Meta, where he supported product development, algorithm engineering, and acquisitions. He was also a senior analytics expert at McKinsey and Co. Weiner is a board member at nonprofits Enduring Hearts and Docs for Tots. He holds a bachelor's degree from Carnegie Mellon University and a master's from Northwestern University. Stay in touch with us by joining our LinkedIn group, AI for Leaders at mitsmr.com/AIforLeaders or by following Me, Myself, and AI on LinkedIn. We encourage you to rate and review our show. Your comments may be used in Me, Myself, and AI materials.

En el Radar Empresarial de hoy analizamos la nueva apuesta de la compañía farmacéutica Walgreens Boots: la empresa quiere competir en este 2025 con una mayor automatización. Es un plan que lleva implementado mucho tiempo: en 2021 comenzaron las primeras pruebas. Tras dos años de expansión, Walgreens decidió parar y mejorar el servicio. Ahora se dispone en este 2025 a dar una enorme vuelta de tuerca a su negocio. ¿Para qué servirá esta apuesta por la automatización? La compañía utiliza robots para llenar miles de recetas para pacientes que toman medicamentos y con esto liberar a sus trabajadores de trabajos más repetitivos y que puedan tener más tiempo para atender a los clientes. Según declararon fuentes de la empresa a la CNBC, espera que sus 11 centros de microcumplimiento atiendan a más de 5000 tiendas para fin de año, frente a las 4800 de febrero y las 4300 de octubre de 2023. La compañía viene de un primer trimestre bastante decepcionante con su beneficio por acción. Walgreens registró una pérdida en el beneficio por acción de 31 centavos cuando el periodo anterior fue de 8 centavos. Eso sí, los ingresos de la compañía aumentaron un 7,5% y llegaron hasta los 39.000 millones de dólares. La compañía busca efectivo a largo plazo, para llevar a cabo una reestructuración. Por eso en febrero suspendió por primera vez el pago a los accionistas y también redujo la participación de 10% al 6% en la compañía de distribución de medicamentos Cencora. Esto le dio 300 millones de dólares. La compañía farmacéutica cerrará este año 1200 tiendas como consecuencia de este nuevo plan estratégico. Busca también convertirse en una empresa más especializada. Además, Walgreens lucha contra Amazon en la venta de medicamentos online. Según filtraciones, la compañía proyectaba generar en 2024 1.800 millones de dólares con la venta de fármacos, casi el 50% más que en 2023. Walgreens tampoco ha dicho cuántos medicamentos ha vendido pero sus recetas aumentaron en 2024. Tim Wentworth piensa que la compañía vencerá a Amazon. Walgreens Boots es la segunda cadena farmacéutica más grande de Estados Unidos, solo por detrás de CVS Health. Fue fundada en Chicago en 1901 y en 2014, la compañía acordó comprar el 55% de la empresa suiza Alliance Boots para formar un negocio global.

State Police Sergeant Yuri Bukhenik presented evidence to the jury at the Karen Read murder re-trial, more black smoke out of the Sistine Chapel in Rome, and Mass. AG sued CVS Health over drug prices. Stay in "The Loop" with #iHeartRadio.

Valerie Hope (she/her), CEO, Connect to Joy, and I recap the latest 5 Things (good vibes in DEI) in just 15 minutes. This wee,k our conversation is about Accessible Scandinavian Style, Longer Refills, Cooling Off Hot Flashes, and more!Here are this week's good vibes:Accessible Scandinavian StyleLonger Refills, Shorter BarriersCooling Off Hot FlashesMarriott Stays Firm Against DEI DroughtTrailblazer Swings New LeagueGood Vibes to Go: Bernadette's GVTG: Go see the film Sinners in theatres. Yes, it's a vampire film and it earns its rating, but it's also full of subtext and lots of symbolism, which you should read up on after the fact.Valerie's GVTG: Feeling overwhelmed? Learn how to give yourself a mental reset by watching this video of Valerie's on Instagram.Read the Stories.Connect with Valerie Hope.Subscribe to the 5 Things newsletter.Watch the show on YouTube. Join thousands of readers by subscribing to the 5 Things newsletter. Enjoy some good vibes in DEI every Saturday morning. https://5thingsdei.com/

Get access now to 7 Figure Medicare University:Lifetime access:https://sevenfigureu.com/​In this episode of Seven Figures or Bust, we delve into CVS Health's significant decision to exit the Affordable Care Act (ACA) individual insurance exchanges by 2026.This move will impact approximately 1 million Aetna members across 17 states, as the company shifts its focus toward more profitable sectors like Medicare and Medicaid. We discuss the implications for agents and clients, exploring how this strategic pivot could reshape the health insurance landscape.Gets Leads from Lead heroes here: https://leadheroes.com/Learn more about getting your own VA with Hire Heroes here:  https://app.hireheroes.com/signup?fpr=christian43Join our free private Facebook group for insurance agents: https://www.facebook.com/groups/551409828919739/          Welcome to the Christian Brindle channel brought to you by Christian Brindle & Christian Brindle Insurance Services. This channel is here for the sole purpose of bringing training, tips, success stories, and personal development from Christian Brindle. Christian is a published author, hosts the ever popular Everything Medicare Podcast, and made six figures in the Medicare business by the time he was 25 years old.

Der S&P 500 konnte in den letzten sieben Handelstagen rund 8% zulegen. Das ist der höchste 7-Tagesanstieg seit November 2020. Die Rallye wird an diesem Donnerstag durch die überwiegend robusten Ergebnisse und Aussichten des Tech-Sektors fortgesetzt. Insbesondere die Zahlen von Meta und Microsoft sind ausgesprochen robust, auch was die Aussichten betrifft. Das Meta die geplanten Investitionen erneut ausweitet, kommt auch den Aktien aus dem KI-Universum zugute. Nach dem Closing werden die Ergebnisse von insbesondere Apple und Amazon im Fokus stehen. Abseits dieser Tech-Riesen fallen die seit gestern Abend gemeldeten Zahlen überwiegend gut aus. CVS Health und Robinhood startend ebenfalls entsprechend freundlich in den Tag. Das CVS plant das Angebot an Wegovy on Novo Nordisk auszuweiten, nachdem auch Hims & Hers das Medikament anbieten wird, sorgt bei Eli Lilly für Verkaufsdruck. Die Ertragsaussichten werden außerdem gesenkt. Tesla dementiert einen Bericht im Wall Street Journal, dass man Elon Musk als CEO des Unternehmens ersetzen wird. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

Der S&P 500 konnte in den letzten sieben Handelstagen rund 8% zulegen. Das ist der höchste 7-Tagesanstieg seit November 2020. Die Rallye wird an diesem Donnerstag durch die überwiegend robusten Ergebnisse und Aussichten des Tech-Sektors fortgesetzt. Insbesondere die Zahlen von Meta und Microsoft sind ausgesprochen robust, auch was die Aussichten betrifft. Das Meta die geplanten Investitionen erneut ausweitet, kommt auch den Aktien aus dem KI-Universum zugute. Nach dem Closing werden die Ergebnisse von insbesondere Apple und Amazon im Fokus stehen. Abseits dieser Tech-Riesen fallen die seit gestern Abend gemeldeten Zahlen überwiegend gut aus. CVS Health und Robinhood startend ebenfalls entsprechend freundlich in den Tag. Das CVS plant das Angebot an Wegovy on Novo Nordisk auszuweiten, nachdem auch Hims & Hers das Medikament anbieten wird, sorgt bei Eli Lilly für Verkaufsdruck. Die Ertragsaussichten werden außerdem gesenkt. Tesla dementiert einen Bericht im Wall Street Journal, dass man Elon Musk als CEO des Unternehmens ersetzen wird. Ein Podcast - featured by Handelsblatt. +++Erhalte einen exklusiven 15% Rabatt auf Saily eSIM Datentarife! Lade die Saily-App herunter und benutze den Code wallstreet beim Bezahlen: https://saily.com/wallstreet +++ +++EXKLUSIVER NordVPN Deal ➼ https://nordvpn.com/Wallstreet Jetzt risikofrei testen mit einer 30-Tage-Geld-zurück-Garantie!+++ +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ +++Probier Seeberger Snacks – deine natürliche Energiequelle. Mit dem Code wallstreet könnt ihr euch jetzt 20% Rabatt im Seeberger Onlineshop sichern: https://www.seeberger.de/?utm_campaign=podcast-q1&utm_medium=nativead&utm_source=podcast&utm_content=wallstreet +++ Der Podcast wird vermarktet durch die Ad Alliance. Die allgemeinen Datenschutzrichtlinien der Ad Alliance finden Sie unter https://datenschutz.ad-alliance.de/podcast.html Die Ad Alliance verarbeitet im Zusammenhang mit dem Angebot die Podcasts-Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, klicken Sie hier: https://datenschutz.ad-alliance.de/podcast.html

Dr. Ali Khan has spent his career at the intersection of medicine, public policy, and value-based care. He's also been at the forefront of some of the country's most innovative care delivery models—from Iora Health and CareMore to Oak Street Health and now Aetna, where he serves as Chief Medical Officer of Medicare at Aetna, a CVS Health company. In this episode, Keith Figlioli sits down with Dr. Khan for a conversation about Medicare's future—and what it will take to make the promise of better, more affordable healthcare a reality. A general internist by training, Dr. Khan's path into healthcare began with a deep curiosity about the broader systems shaping people's health. That curiosity took him from Harvard Kennedy School to the exam room to health plans and startups focused on reimagining the primary care experience for complex, underserved populations. Throughout his career, he's gravitated toward organizations trying to solve public-sector problems with private-sector solutions—building care models that prioritize trust, access, and long-term outcomes. Now at the helm of a Medicare Advantage program serving 4.2 million members, Dr. Khan brings a unique vantage point. In this conversation, he shares hard-earned lessons on care model design, what payers and providers need from each other, and why Medicare is at an inflection point. He makes a compelling case for a renewed focus on the fundamentals—not just risk adjustment or benefit design, but operational follow-through, last-mile care coordination, and culturally grounded team-based models that scale. Dr. Khan and Keith discuss: Building care models that hold up under pressure. From Iora to Oak Street, Dr. Khan has seen firsthand that delivering better outcomes at scale requires more than mission—it takes structural rigor. He unpacks four key dimensions—cultural, clinical, operational, and technological—and explains why lasting impact depends on aligning all of them. Whether it's equipping care teams to deliver in complex communities or building systems that can flex and scale, success hinges on getting the foundation right. Why affordability isn't enough—and where Medicare Advantage must go next. With over half of Medicare beneficiaries now enrolled in MA plans, Dr. Khan argues it's time to move beyond the value prop of supplemental benefits and zero-dollar premiums. The next chapter is about proving clinical excellence at scale. That means prioritizing follow-through over features—removing last-mile barriers, improving care coordination, and designing experiences people actually trust.  From transactional to transformative: the evolving role of health plans. Plans have long relied on contractual structures to drive change, but Dr. Khan believes that era is fading. To deliver on the promise of value-based care, plans must shift from passive administrators to proactive partners—investing in infrastructure, surfacing actionable insights, and enabling providers to succeed across Medicare, Medicaid, and commercial populations alike. Where AI meets care delivery. Dr. Khan reflects on the potential of AI to reduce clinical variation, improve medication management, and drive better follow-up for patients—especially those with chronic conditions. But he cautions that technology alone won't move the needle. To truly unlock AI's value in Medicare, plans and providers must embed it within human-centered systems, coordinate care in real time, and ensure new tools support—not replace—the relationships that matter most. As Dr. Khan notes, we're entering a “put up or shut up” era for Medicare Advantage, where scrutiny is high and proof points matter. Yet within that pressure lies opportunity—particularly for those willing to do the unglamorous work of identifying barriers, building connective tissue, and supporting clinical teams in the trenches.

When it comes to pharmacy benefits, no topics make headlines like GLP-1s and weight loss programs. On this episode of HR Benecast,  Dr. Lia Rodriguez and Erin Bacon from CVS Health share what makes a clinical weight loss program really work. Listen to hear the latest obesity stats, obesity's link to other chronic conditions, the importance of lifestyle changes and more. 

It's a big week for economic data releases in the US, with the jobs report due on Friday, the ISM manufacturing index and core PCE inflation report ahead of that, as well as the preliminary GDP reading for the March quarter. Here in New Zealand, we'll be watching the latest monthly ANZ Business Outlook survey for any signs of nervousness about the global trade situation, as well as inflation indicators. It'll be a very busy week for global earnings releases, with 180 S&P 500 companies due to report. This will include four of the “Magnificent 7” with Meta and Microsoft reporting on Wednesday, and Amazon and Apple to follow on Thursday. We'll also hear from Coca-Cola, Visa, Caterpillar, CVS Health and Eli Lilly.

In this episode of the AI in Business Podcast, Brett Kiley, Executive Director of Customer Experience and Client Solutions at CVS Health, joins us for a compelling discussion on the evolving landscape of customer interactions. With over two decades of experience, Brett shares how CVS navigates the challenges of personalization, efficiency, and seamless service across their retail, pharmacy, and health services divisions. To access Emerj's frameworks for AI readiness, ROI, and strategy, visit Emerj Plus at emerj.com/p1. 

Amanda Moore is a seasoned leader with extensive experience in privacy strategy, technology, and operations. She currently serves as the Senior Director of Privacy at DIRECTV, where she oversees the company's privacy program with respect to technology and operations. Prior to her role at DIRECTV, she held pivotal positions at CVS Health and AT&T leading technical and business teams. Her career started in information technology but shifted to privacy before the onset of CCPA. Amanda holds the CIPM certifications and is a OneTrust Fellow of Privacy Technology. In this episode… Many organizations invest in privacy technology expecting it to deliver instant compliance, only to find that it fails to integrate with existing tools or processes. Adoption often lags when internal teams see privacy as a barrier or when tools are implemented without clearly defined goals. Choosing privacy technology before businesses understand the specific problem they're meant to solve leads to confusion, inefficiency, and low adoption. One of the most effective ways to boost technology adoption is to start with a clear understanding of business processes and goals before introducing new privacy tech. Successful privacy programs start by mapping business processes and making small, non-disruptive backend adjustments that minimize disruption. Additionally, building internal awareness through roadshows, clear communication, and simplified privacy impact assessments helps shift perceptions and encourages teams to view privacy as a business enabler. In this episode of She Said Privacy/He Said Security, Jodi and Justin Daniels speak with Amanda Moore, Senior Director of Privacy at DIRECTV, about integrating privacy technology into business operations. Amanda highlights how strong internal relationships help position privacy as a business enabler, why reframing communication to various business executives enhances support for privacy initiatives, and how measuring privacy program maturity with the use of technology provides more insight than surface-level metrics. She also discusses methods to increase adoption through internal awareness campaigns and simplified assessments, and the long-term value of reputation-building within organizations.

Arkansas tries to push CVS Health out of the state. Grocery prices tick up despite easing inflation. And Sunoco goes high tech with artificial intelligence.

S&P futures are pointing to a higher open, up +1.71%, as equity markets rebound following recent volatilities. Asian equities were broadly higher today, led by a +5.6% surge in Japan's Nikkei, while other markets posted more modest gains. European equities are staging recoveries in early trades, with major indices up near +2%. For today's highlight, Trump threatened China with an additional 50% tariff unless Beijing removes its retaliatory levies. China's Commerce Ministry responded, vowing to "fight to the end" if the US escalates further. Companies Mentioned: Marvell Technology, CVS Health

Today, we're excited to get to know Dr. Ali Khan, Chief Medical Officer of Aetna Medicare, overseeing healthcare services for over 4 million members. His career spans across some of the most impactful value-based care organizations, including Oak Street Health, CareMore, and Iora Health. He is also an adjunct lecturer at Northwestern University's Kellogg School of Management and serves on the clinical faculty of the Yale School of Medicine. Additionally, Dr. Khan is a director on the American Board of Internal Medicine. Also a trusted advisor on Pear's Health Industry Council.Before Aetna, Dr. Khan played a key role in Oak Street Health's rapid expansion, scaling it from 21 to 200+ clinics, culminating in its acquisition by CVS Health. Prior to that, he was instrumental in CareMore Health's growth and innovation in care delivery for vulnerable populations.He holds an MD-MPP from Virginia Commonwealth University and Harvard Kennedy School, completed his residency at Yale, and has taught at institutions like Northwestern Kellogg and Yale School of Medicine.As a leader in value-based care, he has firsthand experience in building, scaling, and optimizing healthcare startups—making his insights invaluable for founders, investors, and industry leaders navigating the complex world of healthcare innovation.

LIVE from Transform 2025 in Las Vegas! Amira Barger is an award-winning Executive Vice President of Communications and Head of DEI Advisory at Edelman, providing senior reputation management and polycultural counsel to clients across the globe. Recently named Woman of the Year by Women Health Care Executives, Top 100 Executives by Involve People, Top CMOs of 2024 by the CMO Alliance, Top 50 Global DEI Professionals by OnConferences, Top 100 People Leaders by Mogul, Fearlessly Authentic Leader by Leaderology, and 30 under 40 in Healthcare Innovation by Business Insider – Amira is a scholar, practitioner and thought leader who brings more than 20 years of experience in strategic communications that reach stakeholders, mobilize the community and inspire action. Amira has global experience in pharma/healthcare communications, corporate branding, web and social media, M&A experience, media relations, team management, sustainability/social impact, reputation management, and DEI. Throughout her career, Amira has utilized these competency areas for clients such as: CVS Health, Eli Lilly, Walgreens, Hologic, Genentech, Pfizer, GSK/Haleon, BMS, Zoetis, Alkermes, Regeneron, Amgen, Medtronic, Children's Miracle Network, Kaiser Permanente, First 5 Los Angeles, Covered California, Centers for Disease Control and Prevention, FEMA, and California Community Colleges. Adam and Amira discuss: - How does “niceness” in workplace culture hold back real DEI progress, and what should leaders do instead? - Challenging Workplace Norms to Advance DEI and Justice - Empowering Women in Leadership - Valuing the Whole Human - "How can leaders move beyond surface-level well-being initiatives to truly create workplaces that honor employees as whole humans, not just workers? Connect with Amira: https://www.linkedin.com/in/amirabarger/ Live from Transform 2025, we're bringing you an exclusive podcast series packed with insights from some of the brightest minds in hiring, talent strategy, and workforce transformation! In this series, we've got incredible guests from Okta, Tubi, Edelman, Greenhouse, Findem, and more, sharing how top organizations are rethinking hiring, culture, and talent acquisition in today's fast-changing world. Greenhouse combines a structured, data-driven hiring approach with AI-embedded workflows that empower recruiters to focus on strategic, high-impact work. From sourcing top talent to personalizing the candidate experience, Greenhouse streamlines and optimizes the entire hiring process. This ensures that every hire is the right hire—eliminating bias, creating fairness, and helping teams make smarter, faster decisions. Over 7,500 companies, including HubSpot, Duolingo, and J.D. Power, trust Greenhouse to build better teams and turn talent into a strategic advantage. Want to learn how today's top companies are winning the talent game? Tune in now and visit Greenhouse.com to transform the way you hire. Thanks for listening. Please follow us on Instagram @NHPTalent and X @AdamJPosner. Visit www.thePOZcast.com for all episodes

CVS Health unveils the results of their new Harris Poll survey, ten years after the pharmacy removed tobacco from its shelves

O mercado de estética no Brasil turbinou o faturamento da Royal Face, pioneira em procedimentos de harmonização facial. Em 2024, a companhia com 270 unidades espalhadas pelo Brasil faturou mais de 300 milhões de reais e tem planos para seguir expandindo. André Alves, o CEO da Royal Face, fala sobre o mercado de estética, segurança e garantia dos procedimentos, negócios e os planos para os próximos anos. Conteúdo patrocinado ROYAL FACE Torne-se um franqueado da maior rede de estética do Brasil https://materiais.royalface.com.br/administradores CÂMBIO Proteja os ganhos do seu negócio com a Wise Empresas. Saiba mais por aqui https://adm.to/49u6gbG SEO Solicite uma análise gratuita da LabMídia e destrave o potencial das buscas orgâncias para sua empresa https://adm.to/40t4XFHSobre o entrevistadoAndré Alves é CEO da Royal Face, maior rede de estética e harmonização facial do Brasil. Foi Presidente da Decolar.com e VP de operações da CVS Health (que comprou a Drogaria Onofre), onde reestruturou as operações da companhia com implantação do E-commerce, logística e Televendas. Também atuou no Grupo Renner S/A, um dos principais varejistas de moda do país, onde foi Diretor de Unidade de Negócios e conduziu reestruturação do E-commerce da Renner e foi responsável pelas áreas de negócios da Camicado e Youcom. Também foi VP comercial na Saraiva e como diretor Latam de E-business na Phillips. André Alves é Graduado em Desenho Industrial na Universidade do Rio de Janeiro, Pós-Graduado na Fundação Getúlio Vargas e fez MBA na Universidade Federal do Rio de Janeiro.See omnystudio.com/listener for privacy information.

In this week's Omni Talk Retail Fast Five news roundup, sponsored by the A&M Consumer and Retail Group, Simbe, Mirakl, Ocampo Capital and Infios, A&M's David Schneidman and Chris Creyts joined Chris and Anne to discuss: - CVS Health's rollout of “mini-stores,” i.e. smaller stores with pharmacies but a limited retail selection - Loblaw identifying U.S. made products at shelf with a new tariff symbol - Google Shopping's new AI search features - Reckitt's claims that it has reduced product development lead times by over 60% with generative AI - And closed with an examination of Portillo's launch of its new loyalty program, not through an app, but through a digital wallet There's all that, plus Blue Steel, airline preferences, and moonlighting as social media influencers. Music by hooksounds.com

Welcome to Omni Talk's Retail Daily Minute, sponsored by Mirakl. In today's Retail Daily Minute:CVS Introduces Mini-Store Pharmacy Concept – In a strategic pivot, CVS Health is launching smaller pharmacy-focused stores, eliminating general retail to streamline operations and enhance healthcare access.Portillo's Perks: A Loyalty Program Without the App Hassle – Portillo's debuts a digital wallet-based rewards program, tackling app fatigue and personalizing perks to drive engagement and customer retention.Trump's Shipbuilding Plan Could Disrupt U.S. Trade – Proposed port fees on China-built vessels may double shipping costs, risk supply chain disruptions, and impact American businesses and consumers.The Retail Daily Minute has been rocketing up the Feedspot charts, so stay informed with Omni Talk's Retail Daily Minute, your source for the latest and most important retail insights. Be careful out there!

CVS Health is laying off 183 workers. The Wills Group will enter its fourth state this year. And Love's Travel Stops and the American Automobile Association have partnered to offer fuel savings.

February 25, 2025: Kate Gamble and Sarah Richardson discuss Tufts University and Kaiser Permanente's groundbreaking Food is Medicine National Network of Excellence. The initiative brings together major healthcare organizations including Blue Cross Blue Shield NC, CVS Health, and Geisinger to integrate food-based interventions into standard medical care. Subscribe: This Week Health Twitter: This Week Health LinkedIn: This Week Health Donate: Alex's Lemonade Stand: Foundation for Childhood Cancer

From law school to leading one of healthcare's most successful value-based care companies, Oak Street Health co-founder Mike Pykos shares the story of building, scaling, and ultimately selling his company to CVS for $11 billion.He reveals the challenges of scaling a new care model, the importance of focusing on outcomes over financials, and what it takes to transform American healthcare.We cover:

Carl Quintanilla and Jim Cramer kicked off the show live from the NYSE, with co-anchor David Faber still in Miami for the FII Priority Summit in Miami. The anchors began the show with UnitedHealth shares sliding following a report that the DOJ is investigating the company's Medicare billing practices. The news impacted other names in the space like Cigna, CVS Health, and Humana, which all moved lower in sympathy. The desk also hit some of the big travel names on the move including Booking Holdings, which rallied on its latest numbers. Also in the mix; the group discussed Elon Musk's appearance at CPAC, where he said he was thinking of auditing the Fed. Squawk on the Street Disclaimer

Latest episode with Dr. Anwar Jebran, director of Population Health Informatics at Oak Street Health, a part of CVS Health.   In this episode, we explore the intersection between technology and medicine. We delve into the innovative world of clinical informatics and the role of artificial intelligence in shaping the future of healthcare.   We discuss the latest trends, challenges, and breakthroughs in the field, and the role of AI and information technology in enhancing patient care, streamlining operations in data management, and clinical analytics. Whether you are a technology enthusiast, a healthcare provider, or curious about the future of medicine, this is an episode you would not want to miss.   #healthcareprofessionals #clinicalinformatics #artificialintelligence #clinicalanalytics #healthcare #electronicmedicalrecords #podcast 

¡Emprendeduros! En este episodio Rodrigo y Alejandro nos dan una actualización de mercado donde hablan del estatus del mercado, los reportes de Empleo e Inflacion, Jerome Powell en el congreso y de Trump y DOGE. Nos dan los reportes de ingreso de Palantir, Alphabet, AMD, Spotify, Uber, McDonald's, Zillow y CVS Health. Después hablan del Fondo Soberano de EEUU y de las actualizaciones de Inteligencia Artificial. Finalmente nos dan el análisis de crypto donde hablan de las liquidaciones mas grandes de la historia, de los cambios de MicroStrategy y de los Meme Coins. ¡Síguenos en Instagram! Alejandro: https://www.instagram.com/salomondrin Rodrigo: https://www.instagram.com/rodnavarro Emprendeduros: https://www.instagram.com/losemprendeduros

 In this episode, Jakob Emerson, Associate News Director at Becker's Healthcare, joins Scott Becker to break down key developments in the payer world. They discuss CVS Health's stock surge, the impact of Medicaid policy changes, and UnitedHealth's aggressive reputation management.

Sandra Cho and Brian Tanquilut break down CVS Health's (CVS) earnings. Sandra calls the report a “huge sigh of relief” after a big drop last year. She says boosting Aetna's profitability will be key to CVS's business. Brian discusses the guidance, saying “there's a lot of excitement about the turnaround” CVS is going through.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-...Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-...Watch on Sling - https://watch.sling.com/1/asset/19192...Watch on Vizio - https://www.vizio.com/en/watchfreeplu...Watch on DistroTV - https://www.distro.tv/live/schwab-net...Follow us on X – / schwabnetworkFollow us on Facebook – / schwabnetworkFollow us on LinkedIn - / schwab-networkAbout Schwab Network - https://schwabnetwork.com/about

Hoy la atención está puesta en el dato de IPC, más alto de lo previsto, y en compañías como CVS Health, Biogen o Kraft Heinz. Lo analizamos con Celso Otero, gestor de Renta 4.

Deutlich über den Erwartungen fallen die Verbraucherpreise für den Januar aus. Um ein halbes Prozent steigen die Verbraucherpreise, erwartet worden war ein Anstieg auf Monatssicht von 0,3%. Die Aktienmärkte verlieren vorbörslich an Boden, der DOW gute 400 Punkte als erste Reaktion und die Technologiebörse NASDAQ rund 1,1 Prozent. Als Reaktion steigen gleichzeitig die 10-jährigen US Staatsanleihen auf über 4,6 % Rendite an und Trump giesst Öl ins Feuer, in dem er die FED auffordert die Zinsen in Einklang mit seinen Zollplanungen zu senken. Ein wilder Ritt heute an der Börse, der noch von etlichen Zahlen, u.a. CVS Health und Vertiv begleitet wird. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • Facebook: http://fal.cn/SQfacebook • Twitter: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

EXKLUSIVER NordVPN Deal ➼ https://nordvpn.com/Wallstreet Jetzt risikofrei testen mit einer 30-Tage-Geld-zurück-Garantie! +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ Ein Podcast - featured by Handelsblatt. Deutlich über den Erwartungen fallen die Verbraucherpreise für den Januar aus. Um ein halbes Prozent steigen die Verbraucherpreise, erwartet worden war ein Anstieg auf Monatssicht von 0,3%. Die Aktienmärkte verlieren vorbörslich an Boden, der DOW gute 400 Punkte als erste Reaktion und die Technologiebörse NASDAQ rund 1,1 Prozent. Als Reaktion steigen gleichzeitig die 10-jährigen US Staatsanleihen auf über 4,6 % Rendite an und Trump giesst Öl ins Feuer, in dem er die FED auffordert die Zinsen in Einklang mit seinen Zollplanungen zu senken. Ein wilder Ritt heute an der Börse, der noch von etlichen Zahlen, u.a. CVS Health und Vertiv begleitet wird.

Wall Street slipped as investors reacted to the latest inflation figures, with Treasury yields seeing their biggest jump since December following Jerome Powell’s testimony. The Consumer Price Index revealed a significant rise in food prices, particularly eggs, adding to inflation concerns. Energy stocks slipped amid an inventory build, while CVS Health soared after its fourth-quarter profit signalled improvement. Gilead Sciences also gained on strong earnings, but Kraft Heinz fell short of expectations. Meanwhile, DoorDash shares jumped on an upbeat outlook, and iron ore prices rebounded due to supply concerns in Australia. Looking ahead, Domain Group is set to report earnings today, while Aussie shares are expected to open higher ahead of Treasury Wine Estates' results. The Aussie dollar is also recovering after US consumer prices rose more than anticipated. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

Transitioning from corporate to entrepreneurship @ 1:32 Jim shares his background, explaining that after a 35-year corporate career, he has transitioned to full-time entrepreneur, coach, speaker, and writer. He discusses the challenges and benefits of this shift, noting that his extensive corporate experience has provided him with valuable tools and insights to apply in his new roles. The value of coaching and mentorship @ 8:06 Jim describes his experience receiving coaching while at Disney, which he credits with helping him become a better leader. He emphasizes the importance of being open to coaching and mentorship, even for experienced professionals, and how it can lead to personal and professional growth. Managing diversity and inclusion in the workplace @ 22:06 Michael and Jim discuss the increasing diversity of the workforce and customer base, and the business imperative for companies to effectively manage diversity and inclusion. They share examples of their experiences with diverse teams and the benefits of embracing different perspectives and cultural backgrounds. Recap and next steps @ 31:23 Michael and Jim wrap up the conversation, providing information on how listeners can connect with Jim further, including his website, LinkedIn, and book. They express their appreciation for the discussion and the insights shared.   Jim Fielding is a respected leader in Experiential Retail, Brand Management, and Media Development, with over 15 years of experience at the President and CEO level. He has emerged as a prominent voice in Authentic Leadership and DEI following the release of his best-selling book, ALL PRIDE, NO EGO, in 2023. Jim's career spans over 30 years with major companies like The Gap, Disney, and 20th Century Fox, where he became known for building collaborative global teams and cultures. Jim works with clients on entrepreneurial ventures, higher education initiatives, and advisory roles. He has presented to organizations such as Oshkosh Inc., Salesforce, and CVS Health, engaging audiences ranging from 50 to 800 attendees. Additionally, Jim is an active angel and venture investor, serving on boards and advising companies in the consumer goods and health sectors. Jim's commitment to higher education includes roles at Indiana University, where he has served on several boards and received multiple honors. His dedication to servant leadership is reflected in his charitable work with organizations like Make-A-Wish International, GLSEN, and the Human Rights Campaign. Jim has been featured in premier press outlets like Harvard Business Review, The Wall Street Journal, New York Post, and Newsweek and on podcasts such as Strategy Skills Podcast, Make It Happen Mondays, Office Hours with David Meltzer, Gay Men, Gay Talk, Life (UN)Closeted, and Follow Your Different. Topics Jim is loves to speak on: Authentic Leadership and the Path to Personal Authenticity The Art of Storytelling and Strategic Brand Planning Creating Safe Spaces for High-Performing Teams and Cultures Jim's Career Journey Working at Disney, Dreamworks, The Gap, Claire's, and Fox Website - https://www.allpridenoego.com/  LinkedIn - https://www.linkedin.com/in/jamesdfielding/ (8.3k+ Followers) Instagram - https://www.instagram.com/allpridenoego/ (~3.4k Followers)

Jim Fielding is a respected leader in Experiential Retail, Brand Management, and Media Development, with over 15 years of experience at the President and CEO level. He has emerged as a prominent voice in Authentic Leadership and DEI following the release of his best-selling book, ALL PRIDE, NO EGO, in 2023. Full episode link: https://bit.ly/JimFieldingPodcast Jim's career spans over 30 years with major companies like The Gap, Disney, and 20th Century Fox, where he became known for building collaborative global teams and cultures. Jim works with clients on entrepreneurial ventures, higher education initiatives, and advisory roles. He has presented to organizations such as Oshkosh Inc., Salesforce, and CVS Health, engaging audiences ranging from 50 to 800 attendees. Additionally, Jim is an active angel and venture investor, serving on boards and advising companies in the consumer goods and health sectors. Additionally, Jim is an active angel and venture investor, serving on boards and advising companies in the consumer goods and health sectors. Jim's commitment to higher education includes roles at Indiana University, where he has served on several boards and received multiple honors. His dedication to servant leadership is reflected in his charitable work with organizations like Make-A-Wish International, GLSEN, and the Human Rights Campaign. Jim has been featured on premier press outlets like Harvard Business Review, The Wall Street Journal, New York Post, Newsweek and on podcasts such as Strategy Skills Podcast, Make It Happen Mondays, Office Hours with David Meltzer, Gay Men, Gay Talk, Life (UN)Closeted, Follow Your Different.

In this week's Omni Talk Retail Fast Five news roundup, sponsored by the A&M Consumer and Retail Group, Simbe, Mirakl, Ocampo Capital, and Scratch Event DJs, Shoptalk's VP of Original Content & Strategy, Ben Miller, joined Chris and Anne to discuss: - CVS Health's new app rollout - Beyond buying back BuyBuy Baby - Walgreens' plans to close down 47 of its in-store health clinics in Illinois - IKEA's decision to expand its secondhand furniture marketplace in Europe - And closed with a discussion of whether Walmart+ and Walmart same-day Rx delivery will have the same impact on the pharmacy industry that Walmart+ has had on the grocery business - There's all that, plus we announced our February OmniStart (congrats Joe Coll of Macy's), and Chris and Anne grill Ben on everything from #Tayvoodoo and the Fantastic 4 to what American-made products Ben plans to sneak back home to the UK from Las Vegas in his suitcase. Music by hooksounds.com #RetailNews #WalmartPlus #HealthcareRetail #PharmacyDelivery #RetailTech #RetailInnovation #RetailBusiness #HealthcareTech #RetailIndustry #OmniTalk

Send us a textArtificial intelligence is destined to play a big role in the pharmaceutical industry in 2025.With this rapid growth, what specific changes can we expect in patient support and pharmaceutical marketing?And how will that impact healthcare costs and patient experience?In this episode of the HealthBiz Podcast, guest William Grambley, CEO of AllazoHealth, discusses how artificial intelligence and patient-level data can lower operating costs, improve medication adherence, and create tailored solutions for patients at every stage of their journey.TOPICS(0:23) Intro(1:02) Background on William Grambley(2:34) How Naval Service Shaped William Grambley(3:23) The Role of Experience and Work History(6:38) What Brought William to AllazoHealth(9:05) Understanding Compliance, Persistence, and Adherence(10:36) Examining Low Levels of Adherence(12:28) How Issues with Medication Adherence Have Changed Over Time(15:00) Distinguishing Between Adherence and Therapy Initiation(17:32) The Importance of Personalization(20:35) The Future of Pharma and AI in 2025(25:02) Dynamic Change and Personalization(27:36) GLP-1s and Adherence(30:30) Book Recommendations from William Grambley

Shoot us a Text.We're rolling into the big conversations at the 2025 Public Policy Day, where industry leaders and lawmakers shape the future of auto. Plus, CVS is testing a new app feature to unlock products, and Tesla inches toward unsupervised self-driving—though Elon says don't get too excited just yet. Show Notes with links:The press stage is set at ready to go at the 2025 Public Policy Day hosted by WANADA. The 2025 Public Policy Day at the Washington, D.C. Auto Show on January 30 features key industry leaders and policymakers. The day kicks off with a networking lunch, followed by opening remarks from John O'Donnell and a keynote discussion with Senator Bernie Moreno (R-OH) and Devon Haynie (U.S. News & World Report).Highlights include vehicle reveals from Stellantis (Dodge Charger Daytona, Jeep Wagoneer S) and Nissan (2025 Murano), plus an Aston Martin Vanquish presentation by Bouch Siaf. A fireside chat features Todd Inman (NTSB) and Dave Shepardson (Reuters), while Alex Kwanten presents the Best Cars for the Money Awards.Industry roundtables cover consumer insights (featuring Thomas Castriota, Paul J Daly) and tax/trade policy (Jennifer Safavian, Cody Lusk, Bill Long). The event closes with Michael Cottone (Volvo) and John Bozzella (Alliance for Automotive Innovation).The day concludes with an exclusive Sneak Peek Reception of the Auto Show, presented by Events DC.Elon Musk recently announced that Tesla has initiated "unsupervised self-driving" at its Fremont factory. However, this development is currently limited to vehicles autonomously navigating within the factory premises.Tesla released a video showing cars driving themselves from the production line to loading docks without human intervention.This internal application covers a 1.2-mile route on private factory roads at low speeds.Musk has previously set ambitious timelines for unsupervised self-driving, including a driverless cross-country trip by 2018, which have not been met.The current implementation is a step forward but remains far from the full autonomous driving capabilities promised to consumers.Musk's latest projection targets unsupervised self-driving in California and Texas by the second quarter of 2025.CVS is piloting a new feature in its app that allows customers to unlock anti-theft cabinets themselves, aiming to enhance the shopping experience.The feature is currently being tested in three New York City stores.To use it, customers must be logged into the CVS app, connected to the store's Wi-Fi, and have Bluetooth enabled.This initiative addresses customer frustration with locked cabinets, which, while deterring theft, often inconvenience shoppers.CVS plans to expand the test to 10 to 15 additional stores, including locations on the West Coast."People really, really dislike locked cabinets," said Tilak Mandadi, executive vice president at CVS Health.Hosts: Paul J Daly and Kyle MountsierGet the Daily Push Back email at https://www.asotu.com/ JOIN the conversation on LinkedIn at: https://www.linkedin.com/company/asotu/ Read our most recent email at: https://www.asotu.com/media/push-back-email

In this episode, Scott Becker analyzes the year-to-date stock performance of UnitedHealthcare, CVS Health, Cigna, and Elevance Health.

A.M. Edition for Dec. 19. Late-breaking objections by the president-elect and Elon Musk to a bipartisan spending bill raise the prospects of a government shutdown. Plus, WSJ Europe finance editor Alex Frangos discusses how global markets are processing yesterday's Fed-fueled selloff. And the Department of Justice sues CVS Health over its alleged role in contributing to the opioid crisis. Luke Vargas hosts. Sign up for the WSJ's free What's News newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Plus: The Justice Department is suing CVS Health for the pharmacy chain's alleged role in the opioid crisis. And, the Bank of Japan holds interest rates steady citing uncertainties in the U.S. outlook. Luke Vargas hosts. Sign up for WSJ's free What's News newsletter.   Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Scott Becker discusses  the performance of five stocks that faced sharp declines, including Humana, Marvell Technology, CVS Health, Reddit, and Rivian.

This CEO Worked With Ray Dalio & Wants To Improve Healthcare: Mark Bertolini CEO Oscar Health $OSCR Great timeless lesson from Mark = "The Leading Cause Of Failure Is Success" Guest: Mark Bertolini CEO Oscar Health OSCR Website: https://www.hioscar.com/ Ticker: $OSCR Bio: Mark T. Bertolini is the Chief Executive Officer of Oscar Health, a leading healthcare technology company dedicated to making a healthier life accessible and affordable for all. Mark is former Co-Chief Executive Officer of Bridgewater Associates, the world's largest and most successful hedge fund. Mark is also a national health care thought leader, and the former Chairman and CEO of Aetna Inc. At Aetna, Mark assumed the role of CEO in November 2010, and of Chairman in April 2011. In November 2018, he stepped down as Chairman and CEO and served as a Director of CVS Health Corporation upon completion of CVS Health's acquisition of Aetna, valued at $69 billion. Throughout Mark's tenure at Aetna, he led the company's transition from a traditional health insurance company to a consumer-oriented health care company focused on delivering holistic, integrated care in local communities. Before joining Aetna, Mark held executive positions at Cigna, NYLCare Health Plans, and SelectCare, Inc., where he was President and Chief Executive Officer. He serves as a director of Verizon Communications Inc. (communications and technology solutions), Thrive Global (sustainable, science-based solutions to enhance well-being, performance and purpose), and the FIDELCO Guide Dog Foundation (non-profit organization that breeds, trains and places German Shepherd guide dogs with people who have visual disabilities). --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Carl Quintanilla, Jim Cramer and David Faber led off the show with Nvidia in correction territory, down more than 10% from its 52-week high and flat over the past six months. When will the stock hit bottom? A different story for Tesla: Shares hit a fresh record high on an upgrade from Mizuho. The anchors reacted to President-elect Trump's comments about lowering drug prices and cutting out the "middleman," which weighed on shares of pharmacy benefit manager operators UnitedHealth, Cigna and CVS Health. Also in focus: Stocks under pressure ahead of Wednesday's Fed rate decision, Pfizer rises on 2025 forecast, Alphabet's quantum leap. Squawk on the Street Disclaimer

New bipartisan legislation in Washington aims to break up pharmacy benefit managers after years of scrutiny on PBMs from Congress and the FTC. Health care insurance executive Mark Bertolini is now CEO of Oscar Health, and he spent years leading Aetna and CVS Health. Today, he reflects on American health care, his vision for an improved system, and his own security detail in the wake of UnitedHealthcare CEO Brian Thompson's murder. In a wide ranging and very personal conversation, Bertolini shares his experience with 18 years of chronic pain and the treatment that changed his life. Plus, Representative Josh Gottheimer (D-NJ) is explaining his edited Spotify wrapped, and Elon Musk is inching closer to trillionaire status, thanks to a new Tesla stock milestone.   Mark Bertolini - 17:42 In this episode:Becky Quick, @BeckyQuickJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie Preroll 00:00ad 1 14:28ad 2 36:18TRT 36:44

Carl Quintanilla, Jim Cramer and David Faber led off the show with the "Trump trade." Tesla shares resumed their big post-election rally, on a report stating President-elect Trump's transition team is seeking to ease rules for self-driving cars. The anchors also discussed the newest selections for Trump's cabinet, as well as Elon Musk's role in the battle for positionsincluding Treasury Secretary. Also in focus: Nvidia shares move lower on a report about AI chip server worries, CVS Health makes board changes in a deal with activist investor Glenview Capital, Netflix says the Jake Paul-Mike Tyson fight was a record-breaker, Faber Report on the NBA-Warner Bros. Discovery settlement over broadcast rights.  Squawk on the Street Disclaimer

Plus: Democrats' chances to gain control of the House of Representatives appear to have faded. The new CEO of CVS Health promises a reorganization of the company, including new leadership at its Aetna insurance unit. J.R. Whalen reports. Sign up for the WSJ's free What's News newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Carl Quintanilla, Jim Cramer and David Faber discussed what to make of stocks surging to record highs, sparked by President-elect Donald Trump's election victory over Vice President Kamala Harris. The Dow soared into 1,000-point territory for its best day in two years. The anchors explored the "Trump trade" winners from Elon Musk's Tesla to the big banks. Post-election stock losers were part of the discussion. Also in focus: M&A and regulatory scenarios under a new Trump administration, More woes for Super Micro, CVS Health surges, the rally in Trump Media shares rolls on. Squawk on the Street Disclaimer

In this week's episode of **Market Mondays**, we covered a wide range of key topics related to the current financial landscape. Ian shared his insights on stocks that could perform well if Donald Trump wins the next election, expanding on previous discussions about stocks to watch if Kamala Harris were to win. Troy also delivered an informative presentation on stock options, providing valuable strategies for navigating the market.We dove into the topic of **Bitcoin** and discussed whether it will continue to follow the Quantitative Easing, 4-year cycle. Ian also provided his **trading tip of the week**, emphasizing that "the shorter the time frame, the weaker the signal," offering advice on how to interpret market signals effectively.Another major topic was the **potential acquisition of Expedia by Uber**. We explored what this purchase could mean for both companies and the broader tech industry. We also had a special guest—U.S. Secretary of Education Miguel Cardona—who joined us to discuss the Biden administration's **$4.5 billion student debt relief announcement** and the current status of education in America. This was an insightful conversation about the government's efforts to alleviate financial burdens on students.Additionally, we addressed whether it's a good time to consider **precious metals like gold**, which recently hit a record high. We explored how much of your portfolio should be allocated to precious metals. We also tackled the question, "If I only invest in VTI and QQQM for the long term, will I be fine?" offering a deep dive into these two popular index funds.In a more rebellious approach, we discussed the strategy of holding **2 tech stocks and 3 index funds** (like healthcare and small caps) for broader exposure, challenging the conventional wisdom of sticking to a strict balance of investments. Finally, we highlighted **8 dividend stocks beyond the usual Dividend Kings**, featuring names like Verizon, Pfizer, UPS, Kraft Heinz, T. Rowe Price, Chevron, CVS Health, and Sirius XM, giving investors new options for securing reliable income.EYL University 48 Hour Sale: Enter Code "MarketMondays" at Checkout https://eyluniversity.com (https://eyluniversity.com) #MarketMondays #StockMarket #Investing #Bitcoin #StudentDebtRelief #PreciousMetals #DividendStocks #FinancialFreedom #VTI #QQQM #TechStocks #Education #Uber #Expedia #TradingTipsSupport this podcast at — https://redcircle.com/marketmondays/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

P.M. Edition for Oct. 18. WSJ reporter Alexander Osipovich discusses a wave of pro-Trump bets in one popular betting market. And Journal health reporter Anna Wilde Mathews discusses why CVS Health is getting a new chief executive and a new strategy. Plus, U.S. federal regulators are investigating Tesla's automated-driving technology, following a deadly crash. Tracie Hunte hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dave Edelman is a sought-after advisor on digital transformation and marketing, a professor, and an author. He teaches marketing at Harvard Business School and advises top executives on AI and personalization. Dave began his career as a young consultant at the Boston Consulting Group, where he coined the term “Segment-of-One Marketing.” Dave also guided Aetna (now part of CVS Health) as CMO through its transformation into a digitally oriented, customer-centric brand. Recognized multiple times by Forbes as one of the “Most Influential CMOs in the World” and by AdWeek as one of the “Top 20 Marketing and Technology Executives,” Dave has attracted over 1.1 million followers to his LinkedIn blog. His upcoming book, Personalized: Customer Strategy in the Age of AI, will be published by Harvard Business Press in October.On today's show, Alan and Dave discuss Dave's upcoming book and the importance of personalization for companies. They delve into the '5 Promises of Personalization,' exploring how effective personalization can transform a company's brand and value proposition over time. They also examine the key conditions required for successful personalization marketing, and how the personalization index can be used to assess and enhance a company's personalization practices. Additionally, they discuss how personalization can unlock the growth potential of AI.In this episode, you'll learn: The 5 Promises of Personalization and how they can add value to your companyHow AI can enhance personalized marketingTips around building trust, a key component to personalizationKey Highlights: [01:40] Dave's passion as a jazz player & how it parallels business[03:35] How Dave got into personalization[07:13] Why this book and why now? [09:03] Conditions needed for personalization [13:33] The 5 promises of personalization [18:40] Digging deeper into “Reach Me” [23:10] How trust factors in [25:33] How do you get better at “Delight Me”[28:44] Evolving your value proposition[32:00] Experience of your past that defines you[34:05] Advice to younger self[35:12] A topic that you and other marketers need to learn more about[36:27] Trends or subcultures others should follow[38:18] Largest opportunity or threat to marketers todayLooking for more?Visit our website for the full show notes, links to resources mentioned in this episode, and ways to connect with the guest! Become a member today and listen ad-free, visit https://plus.acast.com/s/marketingtoday. Hosted on Acast. See acast.com/privacy for more information.